A man claims he nearly died after following medical advice from ChatGPT, a case that is now drawing attention to the legal risks of relying on artificial intelligence for health guidance. The incident, which has not been previously reported in detail, adds urgency to a growing debate about who is responsible when AI gives dangerous advice.
What the man says happened
The man, whose name has not been released, said he used ChatGPT to diagnose symptoms and followed the treatment plan the chatbot suggested. That plan, he alleges, brought him to the brink of death. He did not specify the condition or the advice given, but the case is being examined by legal experts and regulators. The man is reportedly considering legal action, though no lawsuit has been filed yet.
The case could become a test for how existing liability laws apply to AI-generated medical advice. Currently, no clear framework exists. If a chatbot gives harmful advice, is the developer liable? The user? The platform? Regulators in several countries are already looking at AI in healthcare, and this incident may accelerate rulemaking. The European Union's AI Act, still under negotiation, would classify medical AI as high-risk and impose strict requirements. In the United States, the FDA has not yet issued specific guidance for general-purpose chatbots like ChatGPT.
Uncertainty around liability could slow investment in AI for health and finance, two sectors where mistakes can be catastrophic. Venture capital firms that have poured money into AI startups may now reassess risk. Developers may need to add stronger disclaimers or limit the scope of what their models can answer. Some companies are already building guardrails, but the legal landscape remains murky. If courts find AI companies liable for user actions based on their output, the cost of doing business in these sectors could rise sharply.
What happens next
The man's legal team is expected to decide within weeks whether to file a lawsuit. That case, if it proceeds, could set a precedent. Meanwhile, regulators in the U.S. and Europe are watching closely. The outcome may determine not just one man's claim, but the future of how AI is deployed in medicine and other high-stakes fields.
